1. Kimura, Motoko Y, Koyama-Nasu, Ryo, Yagi, Ryoji, Nakayama, Toshinori. 2019. A new therapeutic target: the CD69-Myl9 system in immune responses. In Seminars in immunopathology, 41, 349-358. doi:10.1007/s00281-019-00734-7. https://pubmed.ncbi.nlm.nih.gov/30953160/
2. Zhou, Yuan, Bian, Shuhui, Zhou, Xin, Fu, Wei, Tang, Fuchou. 2020. Single-Cell Multiomics Sequencing Reveals Prevalent Genomic Alterations in Tumor Stromal Cells of Human Colorectal Cancer. In Cancer cell, 38, 818-828.e5. doi:10.1016/j.ccell.2020.09.015. https://pubmed.ncbi.nlm.nih.gov/33096021/
3. Qiu, Xiao, Cheng, Shen-Hong, Xu, Fei, Wang, Li-Yang, Zhang, Xin-You. 2020. Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer. In Journal of Cancer, 11, 2348-2359. doi:10.7150/jca.39723. https://pubmed.ncbi.nlm.nih.gov/32127961/
4. Sheng, Meiling, Wang, Qunzhi, Lou, Yabo, Xiao, Yuanchao, Wu, Xiaoming. 2024. MYL9 binding with MYO19 suppresses epithelial-mesenchymal transition in non-small-cell lung cancer. In Physiological genomics, 57, 1-7. doi:10.1152/physiolgenomics.00119.2024. https://pubmed.ncbi.nlm.nih.gov/39437553/
5. Huang, Chu-Han, Schuring, Joyce, Skinner, Jarrod P, Mok, Lawrence, Chong, Mark M W. 2022. MYL9 deficiency is neonatal lethal in mice due to abnormalities in the lung and the muscularis propria of the bladder and intestine. In PloS one, 17, e0270820. doi:10.1371/journal.pone.0270820. https://pubmed.ncbi.nlm.nih.gov/35802750/
6. Lu, Chih-Hao, Wei, Sung-Tai, Liu, Jia-Jun, Yu, Chin-Sheng, Chang, Sunny Li-Yun. 2022. Recognition of a Novel Gene Signature for Human Glioblastoma. In International journal of molecular sciences, 23, . doi:10.3390/ijms23084157. https://pubmed.ncbi.nlm.nih.gov/35456975/